Prime Therapeutics LLC 401(K) Plan — Form 5500 plan (Prime Therapeutics LLC)

Plain-English plan summary

According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, Prime Therapeutics LLC 401(K) Plan is a benefit plan reported by Prime Therapeutics LLC under EIN 26-0076803 and plan number 001. The latest loaded filing year is 2023. The filing reports 7,502 participants and $739,596,817 in end-of-year plan assets, where available in the loaded dataset.

Key reported metrics

Plan sponsor
Prime Therapeutics LLC
EIN
26-0076803
Plan number
001
Plan type
2
Location
Eagan, MN
Latest filing year
2023
Participants
7,502
End-of-year plan assets
$739,596,817

Form 5500 filing history

Filings loaded for this plan
Filing yearParticipantsSchedulesFiling
20237,502H, C20241014102523NAL0027020273001

Reported financial statement (2023 · Schedule H)

Net assets

Total assets (EOY)
$739,596,817
Total liabilities (EOY)
$0
Net assets (EOY)
$739,596,817
Net assets (BOY)
$527,721,661

Income & contributions

Employer contributions
$38,285,581
Participant contributions
$60,480,405
Total contributions
$149,318,679
Total income / additions
$256,720,421

Expenses & distributions

Benefits paid
$44,388,271
Administrative expenses
$444,266
Total expenses
$44,845,265
Net increase / (decrease)
$211,875,156

Service provider compensation (Schedule C)

Reported service provider compensation
ProviderServiceDirect comp.Indirect comp.Year
Financial EnginesADVISOR$213,777not reported in the loaded dataset2023
Fidelity Investments InstitutionalRECORDKEEPER$143,732$02023
SageviewCONSULTANT$51,750not reported in the loaded dataset2023
Bluecross Blue Shield AssociationOTHER SERVICES$20,181not reported in the loaded dataset2023
Cliftonlarsonallen LlpACCOUNTANT/AUDITOR$14,826not reported in the loaded dataset2023

Related Form 5500 pages